| Amgros 2027 1.615.b | Amgros I/S | Pfizer ApS, Desitin Pharma A/S, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Abacus Medicine A/S, Abcur AB, +4 | 67,3 mio. kr. (samlet) | 30.10.2026 |
| Amgros 2027 1.602.a | Amgros I/S | Abcur AB, FrostPharma AB, Baxter A/S, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Aguettant Nordic ApS | 73 mio. kr. (samlet) | 29.10.2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Sandoz A/S, +7 | 46,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Teva Denmark A/S, +5 | 284,6 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.1206.a | Amgros I/S | Øresund Pharma ApS, Aguettant Nordic ApS, Takeda Pharma A/S, Viatris ApS, Abacus Medicine A/S, GE Healthcare A/S, +1 | 240 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S | 32,2 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.606.b | Amgros I/S | Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS | 75,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Abacus Medicine A/S, 2care4 ApS, Orifarm A/S | 26,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.202.a | Amgros I/S | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33,9 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, +6 | 148,1 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, AstraZeneca A/S | 44,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, +3 | 256,3 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, Orifarm A/S, Nordic Prime ApS | 51,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Abacus Medicine A/S, Chiesi Pharma AB, Paranova Danmark A/S, +1 | 33,6 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.201.a | Amgros I/S | 2care4 ApS, LEO Pharma A/S, Abacus Medicine A/S, Viatris ApS, Octapharma Nordic AB, CSL Behring AB, +2 | 101,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.706.a | Amgros I/S | Abacus Medicine A/S, GHN Pharma Nordic AB | 121 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.702.b | Amgros I/S | Orifarm A/S, Abacus Medicine A/S | 3,9 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, +3 | 704 mio. kr. (samlet) | 23.9.2026 |
| Rammeaftale om køb af Livmarli (maralixibat) | Amgros I/S | Abacus Medicine A/S | 36 mio. kr. | 14.9.2026 |
| Amgros 2026 1.162.b | Amgros I/S | Sandoz A/S, Pfizer ApS, Roche Pharmaceuticals A/S, Abacus Medicine A/S | 733 mio. kr. (samlet) | 26.6.2026 |
| Amgros 2026 1.164.a | Amgros I/S | Orifarm A/S, Abacus Medicine A/S | 3,2 mio. kr. (samlet) | 26.6.2026 |
| Amgros 2027 1.1462.a | Amgros I/S | Abacus Medicine A/S | 121 mio. kr. | 25.6.2026 |
| Amgros 2026 1.501.a | Amgros I/S | Sandoz A/S, Abacus Medicine A/S | 9,1 mio. kr. (samlet) | 15.6.2026 |
| Amgros 2027 1.1189.a | Amgros I/S | Octapharma Nordic AB, Abacus Medicine A/S, Takeda Pharma A/S | 516,6 mio. kr. (samlet) | 20.5.2026 |
| Amgros 2026 1.172.a | Amgros I/S | Abacus Medicine A/S, Novartis Healthcare A/S | 55,1 mio. kr. (samlet) | 14.4.2026 |
| Amgros 2026 1.353.b | Amgros I/S | Pfizer ApS, Orifarm A/S, Sandoz A/S, 2care4 ApS, Biogen (Denmark) A/S, Celltrion Healthcare Denmark ApS, +10 | 2,3 mia. kr. (samlet) | 13.3.2026 |
| Amgros 2026 1.986.b | Amgros I/S | Takeda Pharma A/S, Abacus Medicine A/S, CSL Behring AB, Medical Valley Invest AB, Glenmark Pharmaceuticals Nordic AB, STADA Nordic ApS | 125,6 mio. kr. (samlet) | 18.2.2026 |
| Amgros 2026 1.987.a | Amgros I/S | Abacus Medicine A/S | 22,2 mio. kr. | 18.2.2026 |
| Amgros 2026 1.170.b | Amgros I/S | STADA Nordic ApS, Newbury Pharmaceuticals AB, Zentiva Denmark ApS, Accord Healthcare AB, Sandoz A/S, Viatris ApS, +1 | 896 mio. kr. (samlet) | 17.2.2026 |
| Amgros 2026 2.703.b | Amgros I/S | 2care4 Generics ApS, Paranova Danmark A/S, Orifarm A/S, Abcur AB, 2care4 ApS, Abacus Medicine A/S, +3 | 66 mio. kr. (samlet) | 17.2.2026 |
| Amgros 2026 1.974.a | Amgros I/S | Abacus Medicine A/S, Sun Pharmaceuticals Germany GmbH | 20,6 mio. kr. (samlet) | 27.1.2026 |
| Amgros 2026 2.1305.a | Amgros I/S | Abacus Medicine A/S, Viatris ApS | 13,2 mio. kr. (samlet) | 26.1.2026 |
| Amgros 2026 2.1306.b | Amgros I/S | MSD Danmark ApS, EQL Pharma AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, 2care4 ApS, Abcur AB, Abacus Medicine A/S, +1 | 26 mio. kr. (samlet) | 26.1.2026 |
| Amgros 2026 1.450.b | Amgros I/S | Orifarm A/S, Abacus Medicine A/S, Astellas Pharma A/S, 2care4 ApS, Medice Arzneimittel Pütter GmbH & Co KG | 73 mio. kr. (samlet) | 24.12.2025 |
| Amgros 2026 1.708.b | Amgros I/S | Zentiva Denmark ApS, Orifarm A/S, Abacus Medicine A/S, Novo Nordisk Denmark A/S, Eli Lilly Danmark A/S | 321,9 mio. kr. (samlet) | 25.11.2025 |
| Amgros 2026 2.791.b | Amgros I/S | Norgine Danmark A/S, Abacus Medicine A/S, Immedica Pharma AB | 95,9 mio. kr. (samlet) | 25.11.2025 |
| Amgros 2026 1.601.a | Amgros I/S | 2care4 ApS, Hameln Pharma ApS, Abacus Medicine A/S, MSD Danmark ApS, Accord Healthcare AB, Unimedic Pharma AB, +5 | 331,8 mio. kr. (samlet) | 17.11.2025 |
| Amgros 2026 1.1053.b | Amgros I/S | Biocon, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Denmark ApS, Pfizer ApS, Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, +2 | 948,6 mio. kr. (samlet) | 12.11.2025 |
| Amgros 2026 1.1201.a | Amgros I/S | 2care4 ApS, Macure Pharma ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Unimedic Pharma AB, Navamedic AB, +7 | 358,5 mio. kr. (samlet) | 10.11.2025 |
| Amgros 2026 2.1302.b | Amgros I/S | Panpharma Nordic AS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, EQL Pharma AB, Sandoz A/S, Navamedic AB, Abcur AB, +7 | 162 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 1.1203.a | Amgros I/S | LEO Pharma A/S, Mundipharma A/S, Pharmanovia A/S, Øresund Pharma ApS, Orifarm Generics A/S, Paranova Danmark A/S, +5 | 368,5 mio. kr. (samlet) | 30.10.2025 |